Orchard Starts FDA MLD Gene Therapy Filings Orchard Therapeutics has announced they have filed the first module of their rolling BLA with the US FDA for OTL-200, the gene therapy approved as Libmeldy in Europe. The BLA is a “Biologics License Application” that will be reviewed by the FDA. A “rolling BLA” allows Orchard to file the application in multiple parts, which …
Orchard Starts Filings with FDA for MLD Gene Therapy Read More »
Giving Tuesday is not just about today … MLD Foundation is small but mighty – powerful, connected, influential, and active! As you consider your Giving Tuesday gifts today, please think about us and know the importance of every gift, no matter how large or small. As we look into the near future, this is what …
We’re Thinking of all of you It’s just a few minutes into Christmas Day in Portland, Oregon USA as I write this. Mannheim Steamroller is playing in the background but all I keep hearing in my head is Let It Be Christmas by Alan Jackson. That album and the featured song were recorded in 2002, …
Almost two years of COVID, a month of Black Friday, Halloween, Cyber Monday is coming, and we’re already seeing Christmas & Hanukkah. My head is spinning and my internal clock is all messed up! Hidden and almost lost in the midst of all of the hubbub is Thanksgiving. For us, it’s a time to reflect, …
Today MLD Foundation welcomes Affinia Therapeutics to the MLD Family™! Affinia is a US-based biopharma startup working on a new approach to MLD gene therapy. We are excited to share that MLD is their first therapy program! Affinia Therapeutics’ product candidate Anc80L65-ARSA is designed to deliver a functional ARSA transgene via a one-time dose to …
We’ve met hundreds of you face-to-face, talked to many of you on the phone for hours, and have met many many more through the Internet. One thing that stands out is the moms. Yes, there are strong dads, grandparents, extended family, and friends … but it’s the moms that stand out. We’ve met moms of …
Today is the start of the 17th annual WorldSymposium™ Lysosomal Disease annual meeting. WORLD is the preeminent lysosomal disease research and translational science meeting. Over the last decade and a half, its attendance has grown from a couple of hundred to well over 2,000. MLD Foundation has attended 16 of the 17 WORLD meetings. Unfortunately, …
Did you know that today, Tuesday, December 1st, is Giving Tuesday? After a month of “Black Friday” and yesterday’s “Cyber Monday” frenzy, it’s a day to focus on our loved ones! We aren’t asking for your donations … MLD Foundation knows that MLD families have their hands full with their loved ones so for the …
We heard earlier this week that nearly 4 in 5 people are already looking forward to putting 2020 behind us. The pandemic (family safety, work, school, loss of loved ones, individual and community response, social isolation, etc.), US elections, income, health, … it is affected every one of us, and it’s overwhelming. But we are …
Orchard Therapeutics has announced they have filed the first module of their rolling BLA with the US FDA for OTL-200, the gene therapy approved as Libmeldy in Europe.
The BLA is a “Biologics License Application” that will be reviewed by the FDA. A “rolling BLA” allows Orchard to file the application in multiple parts, which they expect to complete by mid-2023. Orchard has requested a priority review by the FDA which could result in a US approval in the first half of 2024.
CONGRATULATIONS to the Orchard team and the many families who have participated in the natural history studies, the clinical trials, and in the more recent PFDD meetings. It has been a long journey to get to this regulatory review filing. MLD Foundation’s first meeting with Professor Naldini’s gene therapy research team was in late 2005 – 18 years ago!
Quick Fact: MLD Foundation's first meeting with Professor Naldini's gene therapy research team was in late 2005 – 18 years ago!
It’s your support that has enabled and empowered us
to serve MLD families for over 21 years
THANK YOU!
Donate using the above button and also consider starting a Facebook Fundraiser!
MLD Foundation (EIN: 93-1320953) is a federally registered 501(c)(3) charity.
All donations are US tax deductible.
© 2023, All rights reserved. MLD Family is a trademark and the stylized MLD Foundation butterfly logo and We C.A.R.E. are registered trademarks of MLD Foundation.
